ICD-10-PCS › X
ICD-10-PCS codes starting with X
734 codes, page 1 of 8. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| X05 | New Technology, Nervous System, Destruction | Not billable |
| X051329 | Destruction of Renal Sympathetic Nerve(s) using Ultrasound Ablation, Percutaneous Approach, New Technology Group 9 | Valid |
| X05133A | Destruction of Renal Sympathetic Nerve(s) using Radiofrequency Ablation, Percutaneous Approach, New Technology Group 10 | Valid |
| X05233B | Destruction of Thoracic Sympathetic Nerve, Cardiac Plexus using Radiofrequency Ablation, Percutaneous Approach, New Technology Group 11 | Valid |
| X053X4B | Destruction of Brain using Focused Ultrasound Therapy, External Approach, New Technology Group 11 | Valid |
| X0H | New Technology, Nervous System, Insertion | Not billable |
| X0HK3Q8 | Insertion of Neurostimulator Lead into Sphenopalatine Ganglion, Percutaneous Approach, New Technology Group 8 | Valid |
| X0HQ05C | Insertion of Leadless Neurostimulator Generator into Vagus Nerve, Open Approach, New Technology Group 12 | Valid |
| X0HQ3R8 | Insertion of Neurostimulator Lead with Paired Stimulation System into Vagus Nerve, Percutaneous Approach, New Technology Group 8 | Valid |
| X0Z | New Technology, Nervous System | Not billable |
| X0Z0X18 | Computer-assisted Transcranial Magnetic Stimulation of Prefrontal Cortex, New Technology Group 8 | Valid |
| X27 | New Technology, Cardiovascular System, Dilation | Not billable |
| X2723CB | Dilation of Inferior Vena Cava and Iliocaval Confluence with Open-structure Polymer Lattice Intraluminal Device, Percutaneous Approach, New Technology Group 11 | Valid |
| X27339B | Dilation of Right Pulmonary Artery with Expandable Intraluminal Device, Percutaneous Approach, New Technology Group 11 | Valid |
| X27439B | Dilation of Left Pulmonary Artery with Expandable Intraluminal Device, Percutaneous Approach, New Technology Group 11 | Valid |
| X27535B | Dilation of Right Subclavian Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 | Valid |
| X27635B | Dilation of Left Subclavian Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 | Valid |
| X27735B | Dilation of Right Axillary Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 | Valid |
| X27835B | Dilation of Left Axillary Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 | Valid |
| X27935B | Dilation of Right Brachial Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 | Valid |
| X27A35B | Dilation of Left Brachial Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 | Valid |
| X27B35B | Dilation of Right Basilic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 | Valid |
| X27C35B | Dilation of Left Basilic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 | Valid |
| X27D35B | Dilation of Right Cephalic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 | Valid |
| X27E35B | Dilation of Left Cephalic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 | Valid |
| X27H385 | Dilation of Right Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27H395 | Dilation of Right Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27H3B5 | Dilation of Right Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27H3C5 | Dilation of Right Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27J385 | Dilation of Left Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27J395 | Dilation of Left Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27J3B5 | Dilation of Left Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27J3C5 | Dilation of Left Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27K385 | Dilation of Proximal Right Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27K395 | Dilation of Proximal Right Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27K3B5 | Dilation of Proximal Right Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27K3C5 | Dilation of Proximal Right Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27L385 | Dilation of Proximal Left Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27L395 | Dilation of Proximal Left Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27L3B5 | Dilation of Proximal Left Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27L3C5 | Dilation of Proximal Left Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27M385 | Dilation of Distal Right Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27M395 | Dilation of Distal Right Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27M3B5 | Dilation of Distal Right Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27M3C5 | Dilation of Distal Right Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27N385 | Dilation of Distal Left Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27N395 | Dilation of Distal Left Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27N3B5 | Dilation of Distal Left Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27N3C5 | Dilation of Distal Left Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27P385 | Dilation of Right Anterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27P395 | Dilation of Right Anterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27P3B5 | Dilation of Right Anterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27P3C5 | Dilation of Right Anterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27P3NC | Dilation of Right Anterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12 | Valid |
| X27P3TA | Dilation of Right Anterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10 | Valid |
| X27Q385 | Dilation of Left Anterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27Q395 | Dilation of Left Anterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27Q3B5 | Dilation of Left Anterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27Q3C5 | Dilation of Left Anterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27Q3NC | Dilation of Left Anterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12 | Valid |
| X27Q3TA | Dilation of Left Anterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10 | Valid |
| X27R385 | Dilation of Right Posterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27R395 | Dilation of Right Posterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27R3B5 | Dilation of Right Posterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27R3C5 | Dilation of Right Posterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27R3NC | Dilation of Right Posterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12 | Valid |
| X27R3TA | Dilation of Right Posterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10 | Valid |
| X27S385 | Dilation of Left Posterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27S395 | Dilation of Left Posterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27S3B5 | Dilation of Left Posterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27S3C5 | Dilation of Left Posterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27S3NC | Dilation of Left Posterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12 | Valid |
| X27S3TA | Dilation of Left Posterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10 | Valid |
| X27T385 | Dilation of Right Peroneal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27T395 | Dilation of Right Peroneal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27T3B5 | Dilation of Right Peroneal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27T3C5 | Dilation of Right Peroneal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27T3NC | Dilation of Right Peroneal Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12 | Valid |
| X27T3TA | Dilation of Right Peroneal Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10 | Valid |
| X27U385 | Dilation of Left Peroneal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27U395 | Dilation of Left Peroneal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27U3B5 | Dilation of Left Peroneal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27U3C5 | Dilation of Left Peroneal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 through FY2024 | Retired |
| X27U3NC | Dilation of Left Peroneal Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12 | Valid |
| X27U3TA | Dilation of Left Peroneal Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10 | Valid |
| X27W39B | Dilation of Thoracic Aorta, Descending with Expandable Intraluminal Device, Percutaneous Approach, New Technology Group 11 | Valid |
| X27X39B | Dilation of Thoracic Aorta, Ascending/Arch with Expandable Intraluminal Device, Percutaneous Approach, New Technology Group 11 | Valid |
| X28 | New Technology, Cardiovascular System, Division | Not billable |
| X28F3VA | Division of Aortic Valve using Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve, Percutaneous Approach, New Technology Group 10 | Valid |
| X28F3WB | Division of Aortic Valve using Leaflet Laceration, Radiofrequency Energy, Percutaneous Approach, New Technology Group 11 | Valid |
| X28M3DC | Division of Ventricular Septum using Transcatheter Septal Scoring Technique, Percutaneous Approach, New Technology Group 12 | Valid |
| X2A | New Technology, Cardiovascular System, Assistance | Not billable |
| X2A5312 | Cerebral Embolic Filtration, Dual Filter in Innominate Artery and Left Common Carotid Artery, Percutaneous Approach, New Technology Group 2 through FY2025 | Retired |
| X2A6325 | Cerebral Embolic Filtration, Single Deflection Filter in Aortic Arch, Percutaneous Approach, New Technology Group 5 through FY2025 | Retired |
| X2A7358 | Intermittent Coronary Sinus Occlusion, Percutaneous Approach, New Technology Group 8 | Valid |
| X2AH336 | Cerebral Embolic Filtration, Extracorporeal Flow Reversal Circuit from Right Common Carotid Artery, Percutaneous Approach, New Technology Group 6 through FY2025 | Retired |
| X2AH34B | Right Common Carotid Artery Cerebral Embolic Filtration, Single Integrated Distal Filter, Percutaneous Approach, New Technology Group 11 | Valid |
| X2AJ336 | Cerebral Embolic Filtration, Extracorporeal Flow Reversal Circuit from Left Common Carotid Artery, Percutaneous Approach, New Technology Group 6 through FY2025 | Retired |
| X2AJ34B | Left Common Carotid Artery Cerebral Embolic Filtration, Single Integrated Distal Filter, Percutaneous Approach, New Technology Group 11 | Valid |
| X2AK34B | Right Internal Carotid Artery Cerebral Embolic Filtration, Single Integrated Distal Filter, Percutaneous Approach, New Technology Group 11 | Valid |
Page 1 of 8
Next